Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval

BACKGROUND: In order to ascertain the impact of a biomarker-based (personalized) strategy, we compared outcomes between US Food and Drug Administration (FDA)–approved cancer treatments that were studied with and without such a selection rationale. METHODS: Anticancer agents newly approved (September...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Natl Cancer Inst
Päätekijät: Fontes Jardim, Denis L., Schwaederle, Maria, Wei, Caimiao, Lee, J. Jack, Hong, David S., Eggermont, Alexander M., Schilsky, Richard L., Mendelsohn, John, Lazar, Vladimir, Kurzrock, Razelle
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2015
Aiheet:
Meta-Analysis
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4857149/
https://ncbi.nlm.nih.gov/pubmed/26378224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv253
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia